TMFBiologyFool

Brian Orelli

Somewhere between his graduate thesis on BRCA1, a gene that causes hereditary breast cancer, and his postdoctoral fellowship in DNA repair, Brian realized he enjoyed analyzing other people's data more than running his own experiments. Having gotten his first taste of how to analyze stocks from The Motley Fool many years prior, it was only fitting that he came full circle and started writing about biotech, pharmaceutical, and medical device companies for Fool.com. He also covers the health insurance industry to keep from going into binary-event overload. When not writing at The Motley Fool or trade journals like Nature Biotechnology and BioWorld, Brian can be found coaching soccer or hanging out at the beach in his hometown of San Diego.

TMFBiologyFool’s Activity

Today

Rule Breakers article.

TMFBiologyFool published an update. 2 hours ago

Yesterday

Stock Advisor article.

TMFBiologyFool published an update. 6:06 PM

NL

Article

TMFBiologyFool published an article 4:40 PM

Novo Nordisk A/S Injecting Future Sales

The diabetes-drug specialist releases earnings and shares positive clinical trial data for future growth.

Rule Breakers article.

TMFBiologyFool published an update. 4:20 PM

NL

Article

TMFBiologyFool published an article 3:05 PM

BioMarin Pharmaceutical Inc.: Solid Earnings, Pipeline Progressing

The biotech is setting itself up nicely for "break even or better on a non-GAAP basis" in 2017.

NL

Article

TMFBiologyFool published an article 12:19 PM

Why Genomic Health, Inc. Earned a Higher Share Price

A solid earnings report gives the cancer-test maker's stock a boost.

Supernova article.

TMFBiologyFool published an . 11:00 AM

Rule Breakers article.

TMFBiologyFool published an update. 12:44 AM

Wed May 4

NL

Article

TMFBiologyFool published an article 3:49 PM

Taking Inventory on Seattle Genetics, Inc. Earnings

Adcetris sales didn't grow as much as hoped, but management blames an inventory drawdown and other factors while sticking with full-year guidance.

Rule Breakers article.

TMFBiologyFool published an update. 2:59 PM

NL

Article

TMFBiologyFool published an article 1:47 PM

Alnylam Pharmaceuticals, Inc.'s Double-Digit "Earnings" Fall

The biotech's numbers are meaningless, but an update on one of its programs sent the stock down.

Tue May 3

Stock Advisor article.

TMFBiologyFool published an update. 11:46 PM

NL

Article

TMFBiologyFool published an article 8:00 PM

Qiagen NV Looks for a Strong Second Half

Investments by the lab-test maker hurt first-quarter earnings but should pay off later in 2016.

Rule Breakers article.

TMFBiologyFool published an update. 4:32 PM

NL

Article

TMFBiologyFool published an article 2:36 PM

3 Things to Watch as Genomic Health, Inc. Releases Earnings

The cancer-test maker is on the road to profitability.

Supernova Boards Post

TMFBiologyFool replied to the Supernova boards. 12:46 PM

Fri Apr 29

Rule Breakers article.

TMFBiologyFool published an update. 4:18 PM

NL

Article

TMFBiologyFool published an article 3:13 PM

Why ImmunoGen, Inc. Was Down Today (Hint: It Wasn't Earnings)

Investors aren't too happy about the biotech changing its clinical trial design.

Thu Apr 28

Rule Breakers article.

TMFBiologyFool published an update. 4:38 PM

Rule Breakers article.

TMFBiologyFool published an update. 4:20 PM

Show More Activity ...

CAPS Stats & Trivia

CAPS Player Rating 92.45
Player Rank 5657 out of 74852
Score 896.29
Score Change Today -48.03
Accuracy 67.14%
Active Picks 73
Total Picks 215
Best Pick MNKD (+235.52)
Worst Pick INCY (-623.74)
Average Score per Pick 4.17
Charms Earned 10
Highest Rated Favorite zzlangerhans
Go to TMFBiologyFool’s CAPS page

Boards Stats & Trivia

Big red star, 1000 posts CAPS All Star SN Explorer 1 Mission Team Member SN Odyssey
Board Posts 1199
Recs Received 1625
People who have rec'd these posts 550
Recs to Posts Ratio (last 30 days) 5.60
Threads Started 130
Threads Started Percentage 10.84 %
Most Frequent Board Buying or Selling a Home
Very First Post Re: How many is enough? (6/6/2001)
Percentage of Posts Rec'd 53.96 %
Show TMFBiologyFool’s 10 Latest Posts